However, it is always best to notify your healthcare provider if you develop an infection so they can ensure your treatment plan remains appropriate for your needs
The lack of long-term safety data means we cannot definitively say whether these cardiovascular effects pose risks for vulnerable populations
There are several FDA-approved GLP-1 agonists, including: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) Orforglipron (Foundayo) Exenatide (Byetta, Bydureon BCise) But, like any medication, GLP-1s may cause side effects
Some patients stop taking meds as a result
Potential side effects of Semaglutide While most patients undergo treatment with Semaglutide without developing any complications, side effects do sometimes occur